Detalhe da pesquisa
1.
Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial.
Br J Cancer
; 130(5): 788-797, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38200233
2.
The impact of clinical trial enrollment on specialty palliative care utilization in pediatric patients with high-grade gliomas.
Pediatr Blood Cancer
; 70(3): e30115, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36458446
3.
Pediatric Central Nervous System Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 20(12): 1339-1362, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36509072
4.
Correction to: Targeting and Therapeutic Monitoring of H3K27M-Mutant Glioma.
Curr Oncol Rep
; 22(5): 47, 2020 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32297022
5.
Targeting and Therapeutic Monitoring of H3K27M-Mutant Glioma.
Curr Oncol Rep
; 22(2): 19, 2020 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32030483
6.
A novel ATXN1-DUX4 fusion expands the spectrum of 'CIC-rearranged sarcoma' of the CNS to include non-CIC alterations.
Acta Neuropathol
; 141(4): 619-622, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33550509
7.
Influence of socioeconomic status on clinical outcomes of diffuse midline glioma and diffuse intrinsic pontine glioma.
J Neurosurg Pediatr
; : 1-9, 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38489807
8.
Rational combination platform trial design for children and young adults with diffuse midline glioma: A report from PNOC.
Neuro Oncol
; 26(Supplement_2): S125-S135, 2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38124481
9.
A road map for the treatment of pediatric diffuse midline glioma.
Cancer Cell
; 42(1): 1-5, 2024 01 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38039965
10.
The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.
Nat Med
; 30(1): 207-217, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37978284
11.
Gene Therapy for High Grade Glioma: The Clinical Experience.
Expert Opin Biol Ther
; 23(2): 145-161, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36510843
12.
Neuroimaging features of FOXR2-activated CNS neuroblastoma: A case series and systematic review.
J Neuroimaging
; 33(3): 359-367, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36806312
13.
Liquid Biopsy in H3K27M Diffuse Midline Glioma.
Neuro Oncol
; 2023 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38096156
14.
Single-molecule systems for detection and monitoring of plasma circulating nucleosomes and oncoproteins in Diffuse Midline Glioma.
bioRxiv
; 2023 Nov 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38045418
15.
Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways.
Cancer Discov
; 13(11): 2370-2393, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37584601
16.
Expanding Access to CNS-TAP: Design, Development, and Initial Use of a Complex Precision Health Specialty Web App for Neuro-Oncology.
Stud Health Technol Inform
; 290: 804-808, 2022 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35673129
17.
Development of immunotherapy for high-grade gliomas: Overcoming the immunosuppressive tumor microenvironment.
Front Med (Lausanne)
; 9: 966458, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36186781
18.
Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma.
Neuro Oncol
; 24(8): 1366-1374, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35137228
19.
Panobinostat penetrates the blood-brain barrier and achieves effective brain concentrations in a murine model.
Cancer Chemother Pharmacol
; 88(3): 555-562, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34115161
20.
Electronic DNA Analysis of CSF Cell-free Tumor DNA to Quantify Multi-gene Molecular Response in Pediatric High-grade Glioma.
Clin Cancer Res
; 26(23): 6266-6276, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33087334